Pharmaceutical Disposal UK
How to Disposal of Laboratory Waste in the UK
We have compiled a list of suppliers who remove Laboratory Chemical Waste in the UK, including: Healthcare waste and Lab Waste, laboratory waste disposal management, Hazardous waste.
Looking for a particular type of Laboratory Waste Removal
Simply use the search box, then use the suppliers website link to enquire or for prices. The businesses listed that supply Chemical Laboratory Waste Removal & Disposal, have a genuine UK presence.
Sections include: Chemical Waste Collection, Food Waste & Ingredient Disposal, Solvent Disposal, Healthcare Waste Disposal, Medical Sharps Disposal, Pharmaceutical Disposal, Laboratory Waste Disposal, Cosmetics Disposal
| Product | Description | |
|---|---|---|
| N2,N2,N7-Trimethylguanosine | N2,N2,N7-Trimethylguanosine, an indispensable compound employed in the biomedical sector, emerges as a key player in scientific exploration. This modified nucleoside finds widespread application in the domain of research and development. In unraveling the intricacies of m6A mRNA methylation, RNA modification, and RNA metabolism, it assumes a pivotal role. With N2,N2,N7-Trimethylguanosine at their disposal, researchers gain unprecedented insights into the multifaceted realms of drug analysis, disease examination, and the mechanisms governing RNA processing, regulation, and translation. Group: Pharmaceutical. CAS No. 40027-70-1. Pack Sizes: 1 mg. Product ID: B2706-209151. Molecular formula: Custom synthesis is available. Send your inquiries for more information. |  London |
| Cefepime hydrochloride hydrate | Cefepime is an extended-spectrum parenteral cephalosporin antibiotic active in vitro against a broad spectrum of gram-positive and gram-negative aerobic bacteria. Cefepime dosing was 1-4 g/day (0.5-2.0 g twice daily) for adults; ceftazidime dosing was 1-6 g/day (0.5 g every 12 hours to 2.0 g every 8 hours). A limited number of cefepime-treated patients received 2 g every 8 hours. The median length of dosing for both cefepime and ceftazidime was 7 days. Cefepime has a decreased propensity to induce beta-lactamases compared with other beta-lactam antibiotics. Cefepime has a pharmacokinetic disposition similar to that of other renally eliminated cephalosporins, with a half-life of approximately 2 hours. Cefepime has demonstrated clinical efficacy against a variety of infections, including urinary tract infections, pneumonia, and skin structure infections. Cefepime is generally well tolerated. Group: Pharmaceutical. CAS No. 123171-59-5. Pack Sizes: 5 g. Product ID: BBF-03810. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Elacridar | Elacridar hydrochloride (GF120918A) is a P-glycoprotein inhibitor, and has been used both in vitro and in vivo as a tool inhibitor of P-glycoprotein (Pgp) to investigate the role of transporters in the disposition of various test molecules. In vitro, GF120918A demonstrated high plasma protein binding across species, although a definitive protein binding evaluation was precluded by poor recovery, particularly in buffer and in mouse, rat, and dog plasma. GF120918A did not demonstrate potent inhibition of several human cytochrome P450 enzymes evaluated in vitro, with IC(50) values well above concentrations anticipated to be achieved in vivo. Together, these data confirm the utility of GF120918A as a tool P-glycoprotein inhibitor in preclinical species and offer additional guidance on preclinical dose regimens likely to produce P-glycoprotein-mediated effects. Group: Pharmaceutical. CAS No. 143664-11-3. Pack Sizes: 100 mg. Product ID: B0084-311800. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
Would you like to list your products on UK Chemical Suppliers?
Our database is helping our users find suppliers everyday.